Search - tctmd.com

Displaying 1 - 20 of 206

Sort: Relevancy | Date

News Daily News

ACC Releases ‘Concise Clinical Guidance’ for Cardiogenic Shock Care

Caitlin E. Cox

March 19, 2025

News Daily News

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

Caitlin E. Cox

June 25, 2024

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Daily News

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Michael O'Riordan

September 13, 2023

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

News Daily News

Method to Overcome CAC Score Variability Hones Risk Stratification

Todd Neale

June 26, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI

Michael O'Riordan

May 13, 2022

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

Yael L. Maxwell

July 13, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Conference News ACC 2021

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

Yael L. Maxwell

May 26, 2021

News Daily News

‘Smart’ Approach Wins for Post-PCI Antiplatelet Prescribing

Yael L. Maxwell

April 19, 2021

News Daily News

Meta-analysis Supports Genotype-Guided P2Y12 Prescription for ACS

Yael L. Maxwell

March 25, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Daily News

Microvascular Thrombi Common in Patients Dying of COVID-19

Michael O'Riordan

January 27, 2021

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

Advertisement

ACC Releases ‘Concise Clinical Guidance’ for Cardiogenic Shock Care

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Method to Overcome CAC Score Variability Hones Risk Stratification

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

OMT Boosts Survival in Revascularized Patients at 10 Years

Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds

‘Smart’ Approach Wins for Post-PCI Antiplatelet Prescribing

Meta-analysis Supports Genotype-Guided P2Y12 Prescription for ACS

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Microvascular Thrombi Common in Patients Dying of COVID-19

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content